Andrea Riposati was born in Italy, and after graduating from Bocconi University with a degree in business, he emigrated to the United States. After receiving his Master of Business Administration from Harvard University, he started his professional career as a strategy consultant for Booz Allen Hamilton.

In the year 2002, Andrea Riposati helped to establish Muse Technologies in the city of Seattle, Washington. This firm developed software for other businesses, such as Boeing and Microsoft, to help them tackle complex product development, supply chain management, and financial risk management challenges.

Andrea Riposati uprooted to New York in 2007 to become Amazon’s Senior Product Manager, and he’s been there ever since. He was responsible for the Marketplace and the Amazon 3D Printing Store (AWS) within Amazon Web Services. Returning to Seattle in 2012, he co-founded Dante Labs with James Kirkland and many others.

Dante Labs is a worldwide genomic information firm developing and commercializing a new class of transformational health and longevity applications based on artificial intelligence and whole genome sequencing (WGS) (AI). Their initial offering is a revolutionary prenatal test known as Seq Baby.

Dante Genomics has offices in San Francisco and Seattle, and the company provides services to more than 50 clients worldwide. These clients include pharmaceutical companies, healthcare providers, life sciences research universities, pharmaceutical companies, venture capital firms, diagnostic labs, foundations, and government agencies.

The company is most well-known for its market-leading genetic testing solutions, which encompass drug metabolism phenotype (DMPK) and pharmaceutics (PGx).

This test is designed to assist expecting parents in determining their unborn child’s risk factors for dozens of illnesses by analyzing a single blood sample taken from the mother during pregnancy.